Buscador de publicacions

Publicacions

  • Torner-Rubies F, Nuñez JH, Inarejos E, Garraus-Oneca M, Suñol M, Deyà-Martinez A and Moreno-Romo D.

    Total calcaneal allograft reconstruction of an Ewing's sarcoma in a child: Outcome and review of the literature

    CANCER REPORTS . 5(9): . Nº de cites: 2

    [doi:10.1002/cnr2.1626]

  • Kobialka P, Sabata H, Vilalta O, Gouveia L, Angulo-Urarte A, Muixí L, Zanoncello J, Muñoz-Aznar O, Gene-Olaciregui N, Fanlo L, Esteve-Codina A, Lavarino C, Javierre BM, Celis-Passini V, Rovira-Zurriaga C, López-Fernández S, Baselga E, Mora J, Castillo SD and Graupera M.

    The onset of PI3K-related vascular malformations occurs during angiogenesis and is prevented by the AKT inhibitor miransertib

    EMBO Molecular Medicine . 14(7): . Nº de cites: 26

    [doi:10.15252/emmm.202115619]

  • Habti M, Miyata S, Côté J, Krauel L and Piché N.

    Bowel obstruction following pediatric abdominal cancer surgery

    PEDIATRIC SURGERY INTERNATIONAL . 38(7): 1041-1045. Nº de cites: 2

    [doi:10.1007/s00383-022-05127-w]

  • Cuadrado-Vilanova M, Liu J, Paco-Mercader S, Aschero MR, Burgeño-Sandoval V, Sirab N, Pascual-Pastó G, Correa G, Balaguer-Lluna L, Castillo H, Pérez-Jaume S, Muñoz-Aznar O, Roldan-Molina M, Suñol M, Schaiquevich P, Aerts I, Doz F, Cassoux N, Lubieniecki F, Benitez-Ribas D, Lavarino C, Mora J, Chantada G, Català-Mora J, Radvanyi F and Carcaboso AM.

    Identification of immunosuppressive factors in retinoblastoma cell secretomes and aqueous humor from patients

    JOURNAL OF PATHOLOGY . 257(3): 327-339. Nº de cites: 7

    [doi:10.1002/path.5893]

  • García-Gerique L, Garcia-López M, Garrido- García A, Gómez-González S, Torrebadell-Burriel M, Prada-Varela E, Pascual-Pastó G, Muñoz-Aznar O, Pérez-Jaume S, Lemos I, Salvador-Marcos N, Vilà-Ubach M, Doncel-Requena A, Suñol M, Carcaboso AM, Mora J and Lavarino C.

    MIF/CXCR4 signaling axis contributes to survival, invasion, and drug resistance of metastatic neuroblastoma cells in the bone marrow microenvironment

    BMC Cancer . 22(1): 669-669. Nº de cites: 10

    [doi:10.1186/s12885-022-09725-8]

  • Mora J.

    Autologous Stem-Cell Transplantation for High-Risk Neuroblastoma: Historical and Critical Review

    Cancers . 14(11): . Nº de cites: 8

    [doi:10.3390/cancers14112572]

  • Gargallo P, Bautista F, Juan-Ribelles A, Izquierdo E, Soriano A, de Rojas T, Escudero A, Lavarino C, Solano P, Hladun R, Rubio-San-Simón A, Martínez-Romera I, Calabria I, Gene-Olaciregui N, Castañeda-Heredia A, de Álava E, Pérez-Martínez A, Astigarraga I, Patiño-García A, Alonso J, Fernández-Teijeiro A, Cañete A and Moreno L.

    Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP)

    CLINICAL & TRANSLATIONAL ONCOLOGY . 24(5): 809-815. Nº de cites: 2

    [doi:10.1007/s12094-021-02759-7]

  • García-Domínguez DJ, Hajji N, López-Alemany R, Sánchez-Molina S, Figuerola-Bou E, Morón Civanto FJ, Rello-Varona S, Andrés-León E, Benito A, Keun HC, Mora J, Tirado ÓM, de Álava E and Hontecillas-Prieto L.

    Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1

    Oncogene . 41(18): 2638-2650. Nº de cites: 14

    [doi:10.1038/s41388-022-02279-w]

  • Alcon C, Martín F, Prada-Varela E, Mora J, Soriano A, Guillén G, Gallego S, Roma J, Samitier J, Villanueva A and Montero J.

    MEK and MCL-1 sequential inhibition synergize to enhance rhabdomyosarcoma treatment

    Cell Death Discovery . 8(1): 172-172. Nº de cites: 5

    [doi:10.1038/s41420-022-00959-w]

  • Gonçalves-Alves E, Garcia-López M, Rodriguez-Hernandez CJ, Gomez-Gonzalez S, Ecker RC, Suñol M, Muñoz-Aznar O, Carcaboso AM, Mora J, Lavarino C and Mateo-Lozano S.

    AC-265347 Inhibits Neuroblastoma Tumor Growth by Induction of Differentiation without Causing Hypocalcemia

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 23(8): 4323. Nº de cites: 3

    [doi:10.3390/ijms23084323]